Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
C
214370
vs
K
KOSPI 200
Over the past 12 months, Caregen Co Ltd has underperformed KOSPI 200, delivering a return of -57% compared to KOSPI 200's +40% growth.
Stocks Performance
214370 vs KOSPI 200
Performance Gap
214370 vs KOSPI 200
Create a free account · No card needed
Performance By Year
214370 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Caregen Co Ltd
Glance View
Caregen Co Ltd develops and sells peptide-based products for the beauty and aesthetic medicine markets. Its business sits between biotechnology and cosmetics: it creates functional peptide ingredients and turns some of them into finished skin care, hair care, and clinic-use products such as fillers and other aesthetic treatments. The company sells to cosmetic makers, medical clinics, distributors, and overseas partners. It makes money by selling ingredients and finished goods, and by licensing its technology or supplying products under partner brands where needed. What makes Caregen different is that its core asset is its peptide technology. Instead of being a broad consumer brand company, it focuses on science-driven formulas that can be sold as raw materials, medical aesthetic products, or licensed products, which gives it several ways to reach the market.
Create a free account · No card needed